Search results
Results from the WOW.Com Content Network
In the trial, gastrointestinal side effects - a known issue with GLP-1 drugs - were common and led to discontinuation of 10% of trial participants who were on the treatment before the end of the ...
Certain lithium compounds, also known as lithium salts, are used as psychiatric medication, [4] primarily for bipolar disorder and for major depressive disorder. [4] Lithium is taken orally (by mouth). [4] Common side effects include increased urination, shakiness of the hands, and increased thirst. [4]
Participants in a clinical trial of an oral form of a GLP-1 drug lost up to 13% of their body weight over just three months, according to results presented by drugmaker Novo Nordisk in early ...
Electroconvulsive therapy (ECT) or electroshock therapy (EST) is a psychiatric treatment during which a generalized seizure (without muscular convulsions) is electrically induced to manage refractory mental disorders. [1] Typically, 70 to 120 volts are applied externally to the patient's head, resulting in approximately 800 milliamperes of ...
The good news is that you can make simple modifications and may be able to rely on natural remedies. Self-care for dry eye syndrome includes daily use of drops, consuming certain foods and ...
8.7% global prevalence in 2020 [2] Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that may ...
Buspirone is not effective as a treatment for benzodiazepine withdrawal, barbiturate withdrawal, or alcohol withdrawal/delirium tremens. [26]SSRI and SNRI antidepressants such as paroxetine and venlafaxine may cause jaw pain/jaw spasm reversible syndrome (although it is not common), and buspirone appears to be successful in treating bruxism on SSRI/SNRI-induced jaw clenching.
September 9, 2024 at 10:22 AM. (Reuters) -Rezolute Inc said on Monday the U.S. Food and Drug Administration had lifted its partial clinical hold on a late-stage study testing the company's ...